A brief on today's top ID news.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
TAXIS Pharmaceuticals Earns FDA QIDP Designation For its Efflux Pump Inhibitor For Pneumonia
Screening Study for Hepatitis B and Hepatitis D Demonstrates Need for Follow-Up Testing
Early Detection of COVID-19 Infection? There's Possibly an App for That
A Passion for Infectious Disease Education and Communication
Invivyd Forms SPEAR Study Group to Investigate Pemivibart for Long COVID and Post-Vaccination Syndrome
Medical Societies Sue HHS and Secretary Kennedy Over COVID-19 Vaccine Policy Changes